Follicular lymphoma: open trials in Japan

8 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center Hospital East, Chiba · Okayama University Hospital, Okayama · National Cancer Center Hospital, Tokyo · The Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-04
NCT07226843
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center Hospital East, Chiba · Okayama University Hospital, Okayama · Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-04
NCT06549595
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Trial Treatment · Phase 3 · AstraZeneca
Bunkyō City · Chiba · Chuo-shi · Fukuoka · Hirakata-shi · Kobe · Kōtoku · Kumamoto · Kurashiki-shi · Kyoto · Minatoku · Okayama · Osaka · Sapporo · Sunto-gun · Toyoake-shi · Yamagata · Yokohama
Registry updated 2026-10-21
NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Trial Treatment · Phase 1 · Pfizer
National Cancer Center Hospital East, Kashiwa
Registry updated 2026-10-15
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Chiba · Kashiwa · Kōtoku · Kumamoto · Niigata · Okayama · Osaka · Yokohama
Registry updated 2026-10-14
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Chiba Cancer Center, Chiba · National Cancer Center Hospital East, Kashiwa · Cancer Institute Hospital of JFCR, Kōtoku · Aichi Cancer Center Hospital Clinical Oncology, Nagoya · Yokohama Municipal Citizens Hospital, Yokohama
Registry updated 2026-10-05
NCT06542250
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Chūōku · Kashiwa
Registry updated 2026-09-30
NCT06911502
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Trial Treatment · Phase 3 · Celgene
University of Yamanashi Hospital, Chūō · National Cancer Center Hospital, Chuo Ku · National Hospital Organization Kyushu Medical Center, Fukuoka · Kyushu University Hospital, Fukuoka · Japanease Red Cross Society Himeji Hospital, Himeji · Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima · Iwate Prefectural Central Hospital, Morioka · Nagoya University Hospital, Nagoya · Aiiku Hospital, Sapporo · Nihon University Itabashi Hospital, tabashi City
Registry updated 2026-05-20

All Follicular lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error